/
Infectious Disease
746Diseases↗
2.3KPipeline Programs↗
2.2KActive Trials↗
Momentum Score:100/100
Landscape
Disease Coverage Map
Bubble size = actively recruiting trials · Click to explore
Analysis
Phase Distribution
Analysis
Trial Status
13,858
clinical trials
Completed8,060 · 58%
Unknown status1,802 · 13%
Terminated1,105 · 8%
Recruiting1,093 · 8%
Not yet recruiting576 · 4%
Withdrawn539 · 4%
Other683 · 5%
Landscape
Diseases
HIV
Most programs37
Programs
579
Trials
69
Recruiting
Pre
11
P1
5
P2
12
P3
9
Appr
4
Most programs:
GSK
GSKCOVID-19
Most trials256
Programs
208
Trials
53
Recruiting
Pre
168
P1
13
P2
33
P3
41
Appr
57
Most programs:
Pfizer
PfizerHepatitis
Highest activity122
Programs
280
Trials
18
Recruiting
Pre
17
P1
1
P2
11
P3
4
Appr
8
Most programs:
Gilead
GileadPneumonia
2130 programs138 trialsApproved
COVID
2 programs252 trialsPhase 3
HPV
12 programs233 trialsApproved
Sepsis
1685 programs146 trialsApproved
Influenza
884 programs131 trialsApproved
Chronic Hepatitis
83 programs118 trialsApproved
Tuberculosis
88 programs109 trialsApproved
Hepatitis B
43 programs154 trialsApproved
Malaria
371 programs74 trialsApproved
HIV-1
139 programs92 trialsPhase 3
Chronic Hepatitis B
423 programs102 trialsPhase 3
Septic Shock
355 programs66 trialsApproved
Helicobacter Pylori
242 programs74 trialsApproved
RSV
2 programs75 trialsPreclinical
Helicobacter
0 programs74 trials
HIV Infection
145 programs24 trialsApproved
EBV
23 programs66 trialsPhase 3
Meningioma
227 programs37 trialsApproved
Herpes Zoster
119 programs45 trialsApproved
Urinary Tract Infection
118 programs44 trialsApproved
Abscess
35 programs25 trialsApproved
CMV
3 programs56 trialsPhase 2
Respiratory Syncytial Virus
10 programs48 trialsPhase 3
Hepatitis C
330 programs24 trialsApproved
SARS-Cov-2
27 programs45 trialsPhase 1
Helicobacter Pylori Infection
123 programs25 trialsApproved
Epstein Barr Virus
17 programs31 trialsPhase 2
Showing top 30 diseases by activity. 716 more diseases in this therapeutic area.Activity = a momentum score from recent trial starts, number of sponsoring companies, and total trial volume.
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)